<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Deleterious effects of <z:hpo ids='HP_0001297'>strokes</z:hpo> may be ameliorated when thrombolysis (i.e., with recombinant tissue plasminogen activator) restores circulation </plain></SENT>
<SENT sid="1" pm="."><plain>However, reperfusion injury, mediated by oxygen free radicals (reactive oxygen species [ROS]), may limit the benefits of recombinant tissue plasminogen activator treatment </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that, during reperfusion, exogenous nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) would reduce <z:hpo ids='HP_0001297'>stroke</z:hpo> size by quenching ROS </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: To investigate this hypothesis, we used two in vivo <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion models, i.e., autologous <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> in rabbits and filament middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="4" pm="."><plain>Using these models, we measured ROS levels (rabbit model) and <z:hpo ids='HP_0001297'>stroke</z:hpo> volumes (rat model) in response to <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e>, with and without intracarotid administration of ultrafast NO donor proline NO (proliNO) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In the rabbit <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> model, intracarotid administration of proliNO (10(-6) mol/L) (n = 6) during reperfusion decreased free radical levels from 538 +/- 86 nmol/L in the vehicle-treated group (n = 7) to 186 +/- 31 nmol/L (2,3'-<z:chebi fb="0" ids="23778">dihydroxybenzoic acid</z:chebi>; P &lt; 0.001) and from 521 +/- 86 nmol/L (n = 7) to 201 +/- 39 nmol/L (2,5'-<z:chebi fb="0" ids="23778">dihydroxybenzoic acid</z:chebi>; P &lt; 0.002) </plain></SENT>
<SENT sid="6" pm="."><plain>In the rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model, intracarotid administration of proliNO (10(-5) mol/L) (n = 10) during reperfusion reduced the <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> volume from 256 +/- 48 mm3 in the vehicle-treated group (n = 8) to 187 +/- 41 mm3 (P &lt; 0.005) </plain></SENT>
<SENT sid="7" pm="."><plain>In both experimental groups, intracarotid infusion of proliNO did not affect regional cerebral blood flow, mean arterial blood pressure, or brain and body temperatures </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The beneficial effects of early restoration of cerebral circulation after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> were enhanced by intracarotid infusion of proliNO, most likely because of ROS scavenging by NO </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest the possibility of preventive treatment of reperfusion injury using NO donors </plain></SENT>
</text></document>